Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M93.7Revenue (TTM) $M--Net Margin (%)--Altman Z-Score20.2
Enterprise Value $M49.5EPS (TTM) $-0.3Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.4Pre-tax Margin (%)--Higher ROA y-yY
Price/Book2.210-y EBITDA Growth Rate %-7.2Quick Ratio22.6Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %1.3Current Ratio22.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-36.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-38.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M82.9ROIC % (ttm)-2,784.7Gross Margin Increase y-yN

Gurus Latest Trades with CPRX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

CPRX is held by these investors:



CPRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
O'Keeffe Charles BDirector 2016-07-12Buy20,000$0.8139.51view
COELHO PHILIP HDirector 2016-06-17Buy15,000$0.7648.68view
DENKHAUS DONALD ADirector 2016-06-14Buy50,000$0.6573.85view
MCENANY PATRICK JPresident and CEO 2016-06-14Buy105,300$0.6573.85view
MCENANY PATRICK JPresident and CEO 2016-04-26Buy50,000$0.6573.85view
O'Keeffe Charles BDirector 2016-04-26Buy20,000$0.688.33view
COELHO PHILIP HDirector 2016-03-17Buy10,000$1.066.6view
O'Keeffe Charles BDirector 2016-03-16Buy10,000$1.111.8view
Miller SteveCOO 2016-01-11Buy7,933$1.8-37.22view
O'Keeffe Charles BDirector 2016-01-08Buy5,000$1.94-41.75view

Quarterly/Annual Reports about CPRX:

News about CPRX:

Articles On GuruFocus.com
Catalyst Pharmaceuticals Insider Picks Up Shares of Company Oct 05 2015 
Piper Jaffray Remains Bullish on Catalyst Pharmaceuticals Following the Close of its Recent Public O Feb 17 2015 
Weekly CEO Buys Highlight: BH, CLMS, OPK, GPC, CPRX Jan 18 2015 
Weekly CEO Buys Highlight: BH, CLMS, OPK, CPRX, BRT Jan 12 2015 
Largest Insider Buys of the Week Oct 25 2013 
Weekly CFO Buys Highlight: CPRX, APPY, MEI, MNKD Jul 09 2012 
Weekly CFO Buys Highlight: EMC, DVOX, NANX, CPRX, CCRN Jun 04 2012 
Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) Nov 15 2010 
Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) Aug 12 2010 
Catalyst Pharmaceutical Partners Inc. (CPRX) CEO Patrick J Mcenany buys 9,359 Shares Jun 16 2010 

More From Other Websites
Catalyst Pharmaceuticals Announces Participation at SunTrust Robinson Humphrey’s 2017 Orphan Drug... Feb 09 2017
Harvard Bioscience, Inc. (HBIO): Are Hedge Funds Right About This Stock? Dec 16 2016
CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 15 2016
Catalyst Pharmaceuticals Announces First Patient Enrolled in Second Phase 3 Trial of Firdapse in... Dec 15 2016
CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 08 2016
Catalyst Pharmaceuticals Provides Update on its Clinical Trial for Patients with Congenital... Dec 08 2016
Catalyst Pharmaceuticals, Inc. :CPRX-US: Earnings Analysis: Q3, 2016 By the Numbers : December 1,... Dec 01 2016
CATALYST PHARMACEUTICALS, INC. Financials Nov 17 2016
Alexion (ALXN) Offers Long-Term Phase III Data on Kanuma Nov 14 2016
CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 09 2016
Catalyst Pharmaceuticals Announces Third Quarter 2016 Financial Results and Provides Corporate... Nov 09 2016
CATALYST PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Nov 09 2016
Catalyst Pharma (CPRX) Q3 Earnings: Will Stock Surprise? Nov 07 2016
Catalyst Reaches Agreement with FDA (CPRX) Nov 03 2016
Catalyst Pharmaceuticals Inc (CPRX) Isn’t Out Of The Woods With Firdapse Just Yet Nov 01 2016
Catalyst Pharmaceuticals to Hold Third Quarter Financial Results Conference Call and Webcast on... Nov 01 2016
Research Reports Coverage on Generic Drugs Stocks -- Evoke Pharma, Catalyst Pharma, Neurocrine... Oct 31 2016
CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Oct 31 2016
Catalyst Pharmaceuticals Receives Special Protocol Assessment (SPA) from the FDA for Second Phase 3... Oct 31 2016
Here’s Why Catalyst Pharmaceuticals, Resolute Energy, Nutanix & Two Other Stocks Are Trading... Oct 05 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)